Human serum albumin (HSA) is the most abundant protein in blood and has a 19-day in vivo half-life, the longest human blood protein. HSA has also been extensively studied as a drug carrier in a wide variety of clinical applications. HSA-binding, compared with HSAfusion, is promising strategy for extending the plasma half-life of protein therapeutics. The construction of albumin-binding drugs requires assessment of a large enough quantity of HSA-binding peptide candidates for conjugation with therapeutic proteins. Here, we report a back-of-the-envelope assessment method to facilitate phage display selection of HSAbinding peptides. With an experimentally determined number of phage titers, we can calculate the specificity ratios and the recovery yields. The recovery yield is calculated using the titers of eluted phage divided by the titers of input phage. The specificity ratio is calculated using the titer of eluted phage from a target-coated plate divided by the titer of eluted phage from a blank-control plate. These parameters are defined as quantitative criteria for panning and characterization of binding phage clones. Consequently, this approach may enable more rapid and low-cost phage display screening of HSA-binding peptides, which could be used as candidates of HSA binders for conjugation with therapeutic proteins.
25 Abstract 26 Human serum albumin (HSA) is the most abundant protein in blood and has a 19-day in vivo 27 half-life, the longest human blood protein. HSA has also been extensively studied as a drug 28 carrier in a wide variety of clinical applications. Albumin-binding, compared with albumin-29 fusion, is promising strategy for extending the plasma half-life of protein therapeutics. The 30 construction of albumin-binding drugs requires assessment of a large enough quantity of HSA-31 binding peptide candidates for conjugation with therapeutic proteins. Here, we report a back-of-32 the-envelope assessment method to facilitate phage display selection of HSA-binding peptides. 33 With an experimentally determined number of phage titers, we can calculate the specificity ratios 34 and the recovery yields. The recovery yield is calculated using the titers of eluted phage divided 35 by the titers of input phage. The specificity ratio is calculated using the titer of eluted phage from 36 a target-coated plate divided by the titer of eluted phage from a blank-control plate. These 37 parameters are defined as quantitative criteria for panning and characterization of binding phage 38 clones. Consequently, this approach may enable more rapid and low-cost phage display 39 screening of HSA-binding peptides, which could be used as candidates of HSA binders for 40 conjugation with therapeutic proteins. 0.5% yeast extract, 0.5% NaCl, 20 g/mL tetracycline) and is used for M13 phage propagation.
91
Since the library phage carries the lacZ gene, phage plaques appear blue when the phage-92 infected ER2738 cells plate on LB-Tet-IPTG-X-gal media (1% bacto-tryptone, 0.5% yeast 93 extract, 0.5% NaCl, 20 μg/mL Tetracycline, 50 μg/mL IPTG, 40 μg/ml X-gal, 1% agarose).
2.2 Phage titer analysis

95
A single E. coli ER2738 colony was inoculated into 10mL LB-Tet medium and incubated 96 at 37 ℃ by shaking until mid-log phase (OD 600 ~ 0.5) for phage titering. Phage solutions were 97 diluted 10-fold serially in TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl) and aliquots of these 98 solutions (50 μL) were added to a suspension of the prepared ER2738 cells (450 μL), 1 for each 99 phage dilution. The phage infected ER2738 cells (100 μL) were then poured from each dilution 100 tube to a LB-Tet-IPTG-X-gal plate and the plates were incubated overnight at 37 °C. We 101 determined the number of phage particles contained in the original stock phage culture by 102 counting the number of plaques formed on the seeded agar plate and multiplying this by the 103 dilution factor. 109 (~2x10 11 phage ) was added to the well of the coated plate and rocked gently to let them absorb 110 for 60 min. Following 10 washes with TBST, the bound phages were eluted with 0.2 M Gly-HCl, 111 pH 2.2. The 100 μL that was eluted was neutralized with 15 μL Tris-HCl (1 M, pH 9.1) 112 immediately. A small amount of eluted phage was titered as described above and the rest of 113 elutes were added to 20 ml ER2738 culture (OD 600 ~ 0.5) to be amplified 4.5 h at 37℃ for the 114 next round.
2.4 Recovery yield and Specificity ratio 116
To evaluate the efficiency of the phage display panning procedure, we created two selection 117 criteria: the recovery yield and the specificity ratio. The recovery yield is the ratio of the titer of 118 the eluted phage to the input phage. The specificity ratio is the titer of the eluted phage from the 119 target coated well to the blank control well. We examined the effects of target concentration screening HSA-binding peptides from the 167 Ph.D.-7 phage display peptide library, using 100 μg/mL and 200 μg/mL HSA concentration, 169 from microplate--binding phages in panning results, the first round of panning using the original 170 phage display peptide library against the blank microplate is not necessary and should be 171 excluded from the panning process. As can be seen from the phage titer results in the panning for 172 100μg/ml HSA coated microplates shown in Table 1 and the corresponding recovery yields and 173 specificity ratios shown in Table 2 , the recovery yield rose significantly in the constant 174 concentration target. Specifically, the third round is 31.9-fold greater than the first round, while, 175 the specificity ratio improved, from 1.65 in the second round to 2.12 in the third round. The 176 increase in the recovery yields after each round indicates that the pools of high affinity phages 177 binding to HSA has been enriched.
178
It is necessary to use specificity ratio to avoid background interference generated by non-179 specific binding (Vodnik et al., 2011) . This is because eluted phages often include both target-180 binding and microplate surface-binding phages, resulting in false-positive panning. Importantly, 181 the specificity ratio in panning rounds 2 and 3 that is larger than 1 indicated that the eluted 182 phages preferred binding to HSA in the target coated well over the blank in the target-uncoated 183 well. The increase of specificity ratio after each round of panning also implies that phages with 184 high affinity for HSA may have been amplified. However, low specificity ratios and recovery 185 yields may result from the presence of a large number of plate-surface-binding phages.
186
Our data of 100 μg/ml and 200 μg/ml HSA target together demonstrated both a recovery 187 yield and specificity ratio increase by each round panning. In 200 μg/mL HSA coated microplate 188 (Table 1) , the recovery yield also increased 3.6-fold in the third round, as in the first round, and 211 more rapid and cost-efficient means of determining which HSA-binding peptides are useful and 212 effective for conjugation with a bioactive protein. 222 may not be the same as that of free HSA-binding peptides binding to HSA. Thus, the specificity 223 ratio can be employed as an initial criterion, or a back-of-the-envelope assessment, to select 224 HSA-binding peptide candidates for fusion with the intended protein drugs. Our proposed 225 strategy is to select the candidate HSA-binding peptides for conjugation with the therapeutic 226 proteins using the specificity ratio, then subjected these to SPR to determine the K D between the 227 fusion protein and HSA.
228 Summary and outlook 229 In summary, both the recovery yield and the specificity ratio are designed to monitor the 230 phage display panning process. The specificity ratio is a critical recognition feature used to 232 demonstrate the target binding affinity and relative specificity of isolated clones from the phage 233 display peptide library. Use of the specificity ratio and recovery yield facilitates phage panning 234 and identification of positive phage clones. Therefore, these two quantitative parameters are 235 amenable to a wide variety of phage display screening applications.
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The selected HSA-binding peptides will be attached to bioactive proteins to prolong their 
